To cite this paper use one of the standards below:
Antimicrobial peptides (AMPs) have attracted considerable attention as alternatives to conventional antibiotics due to their ability to kill microbes with reduced toxicity against eukaryotic cells. Herein, we investigated three membranotropic peptides (MAP, VP22, and IDRY) which exhibit physicochemical properties that include high positive charge and amphipathic character, similar to those observed in AMPs, suggesting potential activity against microorganisms. We evaluated the antimicrobial activity of these candidates against clinically relevant Gram-positive and Gram-negative bacteria (E. coli, S. aureus, and S. enterica), as well as the yeast C.albicans, and investigated peptide-induced structural changes on the surface using Atomic Force Microscopy (AFM). The minimum inhibitory concentration (MIC) was determined by the broth microdilution method. Following the MIC determination, microbial cells were incubated with the peptides, fixed with glutaraldehyde, and analyzed by AFM to obtain 3D topography images of the cell surface. MAP exhibited antimicrobial activity against E. coli, S. aureus, and S. enterica, with a MIC ≥ 120μM. IDRY showed a MIC ≥ 250μM for E. coli and ≥ 500μm for S. aureus and S. enterica. VP22 did not exhibit detectable antibacterial activity against the bacterial strains. In contrast, all three peptides were active against C. albicans, with MIC values ≥ 10μM for MAP, ≥120μM for VP22 and ≥ 31μM for IDRY. AFM analyses revealed significant alterations in the surface topography of peptide-treated cells, characterized by reduced surface compared with the untreated controls, indicating peptide-induced modifications at cell walls. These findings demonstrate that MAP and IDRY exhibit antibacterial action, while VP22 showed activity only against C.albicans. Furthermore, the topographical changes observed by AFM highlight the potential of this technique for investigating, at the nanoscale, the interactions between bioactive peptides and the cell surface of bacteria and fungi, contributing to a better understanding of their possible mechanisms of action.
With nearly 200,000 papers published, Galoá empowers scholars to share and discover cutting-edge research through our streamlined and accessible academic publishing platform.
Learn more about our products:
This proceedings is identified by a DOI , for use in citations or bibliographic references. Attention: this is not a DOI for the paper and as such cannot be used in Lattes to identify a particular work.
Check the link "How to cite" in the paper's page, to see how to properly cite the paper